Literature DB >> 24672214

Olmesartan and drug-induced enteropathy.

Tran H Tran, Hanlin Li.   

Abstract

In three case histories, patients' sprue-like symptoms improved when olmesartan (Benicar) therapy was withheld.

Entities:  

Year:  2014        PMID： 24672214      PMCID： PMC3956379     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  10 in total

1.  Severe spruelike enteropathy associated with olmesartan.

Authors:  Alberto Rubio-Tapia; Margot L Herman; Jonas F Ludvigsson; Darlene G Kelly; Thomas F Mangan; Tsung-Teh Wu; Joseph A Murray
Journal:  Mayo Clin Proc       Date:  2012-06-22       Impact factor: 7.616

2.  Olmesartan-associated sprue-like enteropathy.

Authors:  Peter P Stanich; Martha Yearsley; Marty M Meyer
Journal:  J Clin Gastroenterol       Date:  2013 Nov-Dec       Impact factor: 3.062

3.  The Oslo definitions for coeliac disease and related terms.

Authors:  Jonas F Ludvigsson; Daniel A Leffler; Julio C Bai; Federico Biagi; Alessio Fasano; Peter H R Green; Marios Hadjivassiliou; Katri Kaukinen; Ciaran P Kelly; Jonathan N Leonard; Knut Erik Aslaksen Lundin; Joseph A Murray; David S Sanders; Marjorie M Walker; Fabiana Zingone; Carolina Ciacci
Journal:  Gut       Date:  2012-02-16       Impact factor: 23.059

4.  Duodenal villous atrophy: a cause of chronic diarrhea after solid-organ transplantation.

Authors:  H Weclawiak; A Ould-Mohamed; B Bournet; C Guilbeau-Frugier; F Fortenfant; F Muscari; F Sallusto; C Dambrin; L Esposito; J Guitard; M Abbal; L Rostaing; N Kamar
Journal:  Am J Transplant       Date:  2011-02-07       Impact factor: 8.086

5.  Villous atrophy induced by mycophenolate mofetil in renal-transplant patients.

Authors:  Nassim Kamar; Patrick Faure; Emmanuel Dupuis; Olivier Cointault; Karine Joseph-Hein; Dominique Durand; Jacques Moreau; Lionel Rostaing
Journal:  Transpl Int       Date:  2004-08-21       Impact factor: 3.782

6.  Methotrexate induced sprue-like syndrome.

Authors:  Marta Maia Boscá; Ramon Añón; Empar Mayordomo; Rosana Villagrasa; Nelly Balza; Cirilo Amorós; Juan Ramon Corts; Adolfo Benages
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

7.  Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma.

Authors:  Marisa DeGaetani; Christina A Tennyson; Benjamin Lebwohl; Suzanne K Lewis; Hussein Abu Daya; Carolina Arguelles-Grande; Govind Bhagat; Peter H R Green
Journal:  Am J Gastroenterol       Date:  2013-05       Impact factor: 10.864

8.  Severe villus atrophy and chronic malabsorption induced by azathioprine.

Authors:  Thomas R Ziegler; Concepción Fernández-Estívariz; Li H Gu; Michael W Fried; Lorraine M Leader
Journal:  Gastroenterology       Date:  2003-06       Impact factor: 22.682

9.  Spruelike enteropathy associated with olmesartan: an unusual case of severe diarrhea.

Authors:  Stephanie E Dreifuss; Yutaka Tomizawa; Nicholas J Farber; Jon M Davison; Adam E Sohnen
Journal:  Case Rep Gastrointest Med       Date:  2013-03-13

Review 10.  Mechanisms of drug-induced diarrhoea in the elderly.

Authors:  R N Ratnaike; T E Jones
Journal:  Drugs Aging       Date:  1998-09       Impact factor: 4.271
  10 in total
  3 in total

1.  Duodenal intraepithelial lymphocytosis in Helicobacter pylori gastritis: comparison before and after treatment.

Authors:  Dustin E Bosch; Yong-Jun Liu; Camtu D Truong; Kelly A Lloyd; Paul E Swanson; Melissa P Upton; Matthew M Yeh
Journal:  Virchows Arch       Date:  2020-10-06       Impact factor: 4.064

2.  Sprue-Like Enteropathy Associated With Olmesartan: A New Kid on the Enteropathy Block.

Authors:  Isabel A Hujoel; Alberto Rubio-Tapia
Journal:  GE Port J Gastroenterol       Date:  2016-03-28

3.  Coeliac disease enteropathy and symptoms may be aggravated by angiotensin receptor blockers in patients on a gluten-free diet.

Authors:  Neil O'Morain; Eileen Shannon; John McManus; Vanessa Warner; Hilary Leeson; Helen O'Donovan; Brian Egan; Valerie Byrnes
Journal:  United European Gastroenterol J       Date:  2021-06-29       Impact factor: 4.623
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.